158 related articles for article (PubMed ID: 7699114)
1. Paraffin section immunohistochemistry as an adjunct to morphologic analysis in the diagnosis of cutaneous lymphoid infiltrates.
Ritter JH; Adesokan PN; Fitzgibbon JF; Wick MR
J Cutan Pathol; 1994 Dec; 21(6):481-93. PubMed ID: 7699114
[TBL] [Abstract][Full Text] [Related]
2. Differential diagnosis of malignant and benign cutaneous lymphoid infiltrates: a study of 57 cases in which malignant lymphoma had been diagnosed or suspected in the skin.
Evans HL; Winkelmann RK; Banks PM
Cancer; 1979 Aug; 44(2):699-717. PubMed ID: 582573
[TBL] [Abstract][Full Text] [Related]
3. Assessment of clonality in cutaneous lymphoid infiltrates by polymerase chain reaction analysis of immunoglobulin heavy chain gene rearrangement.
Ritter JH; Wick MR; Adesokan PN; Fitzgibbon JF; Zhu X; Humphrey PA
Am J Clin Pathol; 1997 Jul; 108(1):60-8. PubMed ID: 9208979
[TBL] [Abstract][Full Text] [Related]
4. Atypical cutaneous lymphocytic infiltrate and a role for quantitative immunohistochemistry and gene rearrangement studies.
Fucich LF; Freeman SF; Boh EE; McBurney E; Marrogi AJ
Int J Dermatol; 1999 Oct; 38(10):749-56. PubMed ID: 10561046
[TBL] [Abstract][Full Text] [Related]
5. The role of MT2 and anti-bcl-2 protein antibodies in the differentiation of benign from malignant cutaneous infiltrates of B-lymphocytes with germinal center formation.
Chimenti S; Cerroni L; Zenahlik P; Peris K; Kerl H
J Cutan Pathol; 1996 Aug; 23(4):319-22. PubMed ID: 8864918
[TBL] [Abstract][Full Text] [Related]
6. Malignant lymphomas of the skin: their differentiation from lymphoid and nonlymphoid cutaneous infiltrates that simulate lymphoma.
Burke JS
Semin Diagn Pathol; 1985 Aug; 2(3):169-82. PubMed ID: 3916553
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous lymphoid hyperplasia and cutaneous marginal zone lymphoma: comparison of morphologic and immunophenotypic features.
Baldassano MF; Bailey EM; Ferry JA; Harris NL; Duncan LM
Am J Surg Pathol; 1999 Jan; 23(1):88-96. PubMed ID: 9888708
[TBL] [Abstract][Full Text] [Related]
8. Intraepidermal localization of the clone in cutaneous T-cell lymphoma.
Bagot M; Wechsler J; Lescs MC; Revuz J; Farcet JP; Gaulard P
J Am Acad Dermatol; 1992 Oct; 27(4):589-93. PubMed ID: 1357011
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous lymphoid hyperplasia. Immunologic characteristics and assessment of criteria recently proposed as diagnostic of malignant lymphoma.
Medeiros LJ; Picker LJ; Abel EA; Hu CH; Hoppe RT; Warnke RA; Wood GS
J Am Acad Dermatol; 1989 Nov; 21(5 Pt 1):929-42. PubMed ID: 2808829
[TBL] [Abstract][Full Text] [Related]
10. Expression of a cell-cycle-associated nuclear antigen (Ki-67) in cutaneous lymphoid infiltrates.
Ralfkiaer E; Stein H; Bosq J; Gatter KC; Ralfkiaer N; Wantzin GL; Mason DY
Am J Dermatopathol; 1986 Feb; 8(1):37-43. PubMed ID: 3518522
[TBL] [Abstract][Full Text] [Related]
11. CD68 expression is a discriminative feature of indolent cutaneous CD8-positive lymphoid proliferation and distinguishes this lymphoma subtype from other CD8-positive cutaneous lymphomas.
Wobser M; Roth S; Reinartz T; Rosenwald A; Goebeler M; Geissinger E
Br J Dermatol; 2015 Jun; 172(6):1573-1580. PubMed ID: 25524664
[TBL] [Abstract][Full Text] [Related]
12. Expression of proliferating cell nuclear antigen in cutaneous malignant lymphomas and lymphoid infiltrates.
Qiu BS; Luo JM
Chin Med J (Engl); 1994 Jul; 107(7):496-9. PubMed ID: 7956495
[TBL] [Abstract][Full Text] [Related]
13. [Colchicine sensitivity index: a means of distinguishing benign and malignant lymphocytic cutaneous infiltrates (author's transl)].
Sterry W; Steigleder GK; Nikolai B
Dtsch Med Wochenschr; 1980 Aug; 105(33):1157-9. PubMed ID: 6969652
[TBL] [Abstract][Full Text] [Related]
14. Specific cutaneous infiltrates in patients with myelogenous leukemia: a clinicopathologic study of 26 patients with assessment of diagnostic criteria.
Kaddu S; Zenahlik P; Beham-Schmid C; Kerl H; Cerroni L
J Am Acad Dermatol; 1999 Jun; 40(6 Pt 1):966-78. PubMed ID: 10365929
[TBL] [Abstract][Full Text] [Related]
15. Reliable and cost-effective paraffin section immunohistology of lymphoproliferative disorders.
Segal GH; Stoler MH; Fishleder AJ; Tubbs RR
Am J Surg Pathol; 1991 Nov; 15(11):1034-41. PubMed ID: 1928555
[TBL] [Abstract][Full Text] [Related]
16. Immunoreactivity for bcl-2 protein in cutaneous lymphomas and lymphoid hyperplasias.
Triscott JA; Ritter JH; Swanson PE; Wick MR
J Cutan Pathol; 1995 Feb; 22(1):2-10. PubMed ID: 7751474
[TBL] [Abstract][Full Text] [Related]
17. Variable expression of leucocyte-common (CD45) antigen in CD30 (Ki1)-positive anaplastic large-cell lymphoma: implications for the differential diagnosis between lymphoid and nonlymphoid malignancies.
Falini B; Pileri S; Stein H; Dieneman D; Dallenbach F; Delsol G; Minelli O; Poggi S; Martelli MF; Pallesen G
Hum Pathol; 1990 Jun; 21(6):624-9. PubMed ID: 1693592
[TBL] [Abstract][Full Text] [Related]
18. Immunophenotyping of cutaneous lymphoid infiltrates in frozen and paraffin-embedded tissue sections: a comparative study.
Cerroni L; Smolle J; Soyer HP; Martinez Aparicio A; Kerl H
J Am Acad Dermatol; 1990 Mar; 22(3):405-13. PubMed ID: 2179300
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical characterization of mast cell disease in paraffin sections using tryptase, CD68, myeloperoxidase, lysozyme, and CD20 antibodies.
Li WV; Kapadia SB; Sonmez-Alpan E; Swerdlow SH
Mod Pathol; 1996 Oct; 9(10):982-8. PubMed ID: 8902835
[TBL] [Abstract][Full Text] [Related]
20. Focal lymphoid aggregates (nodules) in bone marrow biopsies: differentiation between benign hyperplasia and malignant lymphoma--a practical guideline.
Thiele J; Zirbes TK; Kvasnicka HM; Fischer R
J Clin Pathol; 1999 Apr; 52(4):294-300. PubMed ID: 10474523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
